This content is from: Premium

Viking Leads Tiger-Related Funds in Latest Biopharma IPO

Viking and Matrix Capital Management are the largest outside investors in Adaptive Biotechnologies.

A company that counts several prominent hedge funds from the Tiger Management crowd among its major investors has filed plans to go public.But it is not a unicorn or an internet, technology, or new media company.Rather, it is the latest among a growing number of fledgling biopharma companies looking to

To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.

Related Content